ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the Mohawk Valley region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the third quarter of 2025. The dividend is payable on Oct. 3, to all shareholders of record as of Sept. 15. At […]
ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the Mohawk Valley region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the third quarter of 2025.
The dividend is payable on Oct. 3, to all shareholders of record as of Sept. 15. At the company’s current stock price, the payment yields just under 1.5 percent on an annual basis.
ConMed is a medical technology company that provides devices and equipment for surgical procedures. Surgeons and other health-care professionals use the firm’s products in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. ConMed reported net sales of $663.6 million in the first six months of 2025, up 3 percent from nearly $644.4 million in the first half of 2024.
Based in Largo, Florida since 2021, ConMed still operates a facility on French Road in New Hartford, where it was formerly headquartered.
